Consequences of Switching 5Î±-Reductase Inhibitors on Prostate Specific Antigen Velocity

Article ID	Journal	Published Year	Pages	File Type
6160293	The Journal of Urology	2010	6 Pages	PDF

Abstract

Results confirm that changing 5Î±-reductase inhibitors drugs can be associated with a clinically significant change in prostate specific antigen velocity. These prostate specific antigen velocity changes could place patients at risk for unnecessary prostate biopsy. Additional prospective studies are warranted.

Keywords

5ARI DHT PSA EDW PSAV 5AR 5α-reductase Prostate specific antigen Enterprise Data Warehouse Drugs Dutasteride Dihydrotestosterone Prostate cancer PSA velocity Lower urinary tract symptoms Generic Finasteride LUTS Benign prostatic hyperplasia BPH prostate-specific antigen Prostate CaP